Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
08/2007
08/22/2007CN101023086A Selected fused heterocyclics and uses thereof
08/22/2007CN101023063A Azine-carboxamides as anti-cancer agent
08/22/2007CN101020677A Cyanoacrylate compounds and their application in pesticide
08/21/2007US7259260 Aromatic ring system with a quinazoline-4-on group linked to the carbon between the dione group, and a metallocenyl group bonding to the nitrogen atom of the imide group via a bivalent aromatic ring
08/21/2007US7259163 Viricides against herpes virus
08/21/2007US7259155 Phosphonic diester derivatives
08/21/2007CA2150940C Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
08/16/2007WO2007092190A2 Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity
08/16/2007WO2007091683A1 Bissquarylium compound
08/16/2007WO2007091622A1 Anti-cancer pharmaceutical composition
08/16/2007WO2007090793A1 Nitrooxy-comprising derivatives of apraclonidine and brimodnidine as al pha2 -adrenergic receptor agonists
08/16/2007WO2007090748A1 Benzamide and heteroarene derivatives
08/16/2007WO2007041365B1 3-cyclyl-2- (4-sulfamo yl-phenyl) -n-cyclyl-propionamide derivatives useful in the treatment of impaired glucose tolerance and diabetes
08/16/2007WO2004007437A9 Urea-substituted and urethane-substituted acylureas, methods for the production thereof and their use as medicaments
08/16/2007US20070191420 Kinase inhibitors
08/16/2007US20070191419 (6R,8S)-6-(spiro[isobenzofuran-1-(3H), 4'-piperidin]-1'-ylmethyl)-5,6,7,8-tetrahydroquinolin-8-ol), exhibiting an antagonism to binding of nociceptin to opioid receptor-like-1 receptors, useful as medicines for diseases associated with pain and appetite control or memory and learning
08/16/2007US20070191407 catalytic chemical preparation of intermediate 4-(2-cyanoethenyl)-2,6-dimethylbenzenamine stereoisomers in presence of palladium chloride; having HIV inhibiting properties
08/16/2007US20070191403 e.g. 3-[{hydroxycarbonylpropyl-amino}-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methylpyrimidine-2,4(1H,3H)-dione; sex-hormone related diseases; anticarcinogenic agent; endometriosis, uterine fibroids, polycystic ovarian disease
08/16/2007US20070191387 Substituted dihydroquinazolines
08/16/2007US20070191380 Kinase inhibitor scaffolds and methods for their preparation
08/16/2007US20070191344 Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases
08/16/2007US20070191333 Antibacterial agents
08/16/2007US20070191318 Process for the preparation of amorphous rosuvastatin calcium
08/16/2007US20070190523 Method and compositions for identifying anti-hiv therapeutic compounds
08/16/2007US20070190355 Material for organic electroluminescence device and organic electroluminescence device utilizing the same
08/16/2007CA2642665A1 Anti-cancer pharmaceutical composition
08/16/2007CA2641501A1 Nitrooxy-comprising derivatives of apraclonidine and brimodnidine as al pha2 -adrenergic receptor agonists
08/15/2007EP1818325A2 3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
08/15/2007EP1817293A1 Diastereomeric purification of rosuvastatin
08/15/2007EP1816913A1 Novel compounds for treatment of cancer and disorders associated with angiogenesis function
08/15/2007EP1523533B1 Luminescent compositions
08/15/2007EP1355887B1 Pyrimidine acyclonucleoside derivatives, preparation method and use thereof
08/15/2007EP1250137B1 Jak/stat pathway inhibitors and the use thereof for the treatment of primary generalized osteoarthritis
08/15/2007CN1331865C Polymorphs and compositions and methods related thereto
08/15/2007CN1331863C Imide analog compounds and its preparation method
08/15/2007CN1331862C Di-aryl acid derivatives as PPAR receptor ligands
08/15/2007CN101018784A Bicyclic amides as kinase inhibitors
08/15/2007CN101018781A Bicyclic N-anilide spirolactam CGRP receptor antagonists
08/15/2007CN101018772A Neurologically-active compounds
08/15/2007CN101016266A Novel amorphous form of erlotinib hydrochloride and its solid amorphous dispersion
08/15/2007CN101016265A Preparation of HIV-1 reverse transcriptase inhibitor and application thereof
08/15/2007CN101015804A Swollen vermiculite loading NiB amorphous alloy catalyst, its prepn. method and application
08/14/2007US7256288 For therapy or prophylaxis of diseases and for improving perception, concentration, learning and/or memory
08/14/2007US7256287 small molecule inhibitors of the IgE response to allergens that are useful in the treatment of allergy and/or asthma or any diseases where IgE is pathogenic
08/14/2007US7256198 Pyrimidoindolones and methods for using same
08/14/2007US7256197 Methods for synthesis of diarylmethanes
08/14/2007US7256195 Preparation of risperidone
08/09/2007WO2007089768A2 4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as jak-2 modulators and pharmaceutical compositions containing them
08/09/2007WO2007089044A1 Process for production of aromatic compound
08/09/2007WO2007088996A1 Trisubstituted amine compounds as inhibitors of -cholesteryl ester transfer protein cetp
08/09/2007WO2007071963A3 Quinazoline derivatives, process for their preparation and their use as anti-cancer agents
08/09/2007WO2007055941A3 Histone deacetylase inhibitors with aryl-pyrazolyl motifs
08/09/2007WO2007038444A3 N-(4-oxo-3,4-dihydroquinazolin-2-yl)butanamides as androgen receptor modulators
08/09/2007US20070185326 Heterocyclic compound
08/09/2007US20070185142 Process for producing substituted aminoquinazolinone derivative, intermediate therefor, and pest control agent
08/09/2007US20070185135 Drug-Polymer Conjugates
08/09/2007US20070185119 Therapeutic agents II
08/09/2007US20070185116 Bicyclic compounds
08/09/2007US20070185091 Bicyclic Heterocycles, Pharmaceutical Compositions Containing These Compounds, Their Use and Processes for Preparing Them
08/09/2007CA2640398A1 4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as jak-2 modulators and pharmaceutical compositions containing them
08/09/2007CA2635531A1 Multicyclic amino acid derivatives and methods of their use
08/08/2007EP1816126A1 Process for preparation of rosuvastatin calcium
08/08/2007EP1814867A2 Aryl pyrimidyl compounds, pharmaceutical compositions comprising them, their use as antimicrobial agents
08/08/2007EP1814552A2 Compounds for treating protein-kinase mediated disorders
08/08/2007EP0937050B1 Halogen pyrimidinyl aryl (thio)ethers as pesticides
08/08/2007CN1330657C Novel piperidine and piperazine derivatives
08/08/2007CN1330644C Hydrolysis of [R(R*,R*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino) carbonyl]-1H-pyrrole-1-heptanoic acid esters with calcium hydroxide
08/08/2007CN1330640C Substituted bicyclic derivatives for the treatment of abnormal cell growth
08/08/2007CN1330639C Crystalline pharmaceutical
08/08/2007CN1330634C Antibacterial agents
08/08/2007CN101014604A 6-phenyl-7-amino-triazolopyrimidines, methods for the production thereof, the use thereof for controlling pathogenic fungi, and agents containing the same
08/08/2007CN101014590A 2, 4, 6-trisubstituted pyrimidines as phosphotidylinositol (PI) 3-kinase inhibitors and their use in the treatment of cancer
08/08/2007CN101014576A Aryl spirolactam cgrp receptor antagonists
08/08/2007CN101014564A Substituted acids for the treatment of respiratory diseases
08/08/2007CN101012259A 3'-prodrugs of 2'-deoxy-beta-l-nucleosides
08/08/2007CN101012200A Process for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinases
08/08/2007CN101012174A Halogenating agents
08/07/2007US7253292 Synthesis of cyclopentadiene derivatives
08/07/2007US7253286 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective
08/07/2007US7253192 Phenyl derivatives comprising an acetylene group
08/07/2007US7253177 Synthesis and antimalarial activity of pyrrolo[3,2-f]quinazoline-1,3-diamine derivatives
08/07/2007US7253174 (Anilino)(halo)pyrimidine derivatives or (anilino)(amino)pyrimidine derivatives; treating rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis.
08/07/2007US7253172 Enzyme inhibitor for treating a non-insulin dependent diabetes mellitus; 3-Amino-4-(3,4-difluorophenyl)butanoyl]-4-[2-({3-[(methylsulfonyl)amino]-phenyl}-amino)-2-oxoethyl]piperazin-2-yl}acetic acid
08/07/2007US7253168 Substituted 1-benzyl-4-substituted piperazine analogues
08/07/2007CA2332007C Adenosine a3 receptor modulators
08/07/2007CA2317589C Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
08/02/2007WO2007087135A2 PIPERAZINES AND PIPERIDINES AS mGluR5 POTENTIATORS
08/02/2007WO2007063702A3 Iminopropene compound and use thereof
08/02/2007WO2007056151A3 Protein kinase inhbitors
08/02/2007WO2007047378A3 Dihydrogen phosphate salt of a prostaglandin d2 receptor antagonist
08/02/2007WO2006113304A3 Combinations, methods and compositions for treating cancer
08/02/2007WO2006081391A3 Compounds for inflammation and immune-related uses
08/02/2007US20070179295 Triazolopyrimidines
08/02/2007US20070179263 Functional material comprising fluorine-containing compound
08/02/2007US20070179166 Reduction of statin ketoesters and purification of diol esters of the statins through selective crystallization; rosuvastatin; HMG-CoA inhibitors
08/02/2007US20070179165 Cyclic compounds
08/02/2007US20070179164 Compounds for modulating TRPV3 function
08/02/2007US20070179140 (1R,2R,3S,4S) N4-(3-Aminocarbonylbicyclo[2.2.1]hept-5-ene-2-yl)-5-fluoro-N2-[3-(1,3-oxazol-2-yl)phenyl]-2,4-pyrimidinediamine, exhibiting antiproliferative, anticarcinogenic or antitumor activity
08/02/2007CA2640375A1 Pyrimidine derivatives
08/02/2007CA2636931A1 Piperazines and piperidines as mglur5 potentiators